These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
    Author: Surwit RS, Gilgor RS, Duvic M, Allen LM, Neal JA.
    Journal: Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959.
    Abstract:
    Twenty-four patients classified as having Raynaud's disease or Raynaud's phenomenon were given bilateral brachial artery injections of reserpine or saline in a double-blind fashion. In the six weeks following injection, there was no indication that reserpine produced clinical improvement or changed vasomotor reactivity in the treated patients. However, intra-arterial reserpine did produce systemic cardiovascular effects lasting up to six weeks. It is concluded that intra-arterial reserpine as used in this study is an ineffective treatment for Raynaud's disease or Raynaud's phenomenon and may have significant adverse effects.
    [Abstract] [Full Text] [Related] [New Search]